# South America Cough Syrup Market > South America Cough Syrup Market Research Report: Size, Share, Trend Analysis By Product (Expectorants, Cough Suppressants, Antihistamines, Combination Medications), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.08% - **2024:** $ 525 Million - **2025:** $ 541.17 Million - **2035:** $ 733 Million - **Key Players:** Johnson & Johnson (US), Pfizer Inc (US), GlaxoSmithKline (GB), Boehringer Ingelheim (DE), Sanofi (FR), Novartis (CH), Reckitt Benckiser Group (GB), AbbVie Inc (US), Mylan N.V. (US) **Report ID:** MRFR/HC/47976-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-america-cough-syrup-market-49730 --- ## Market Summary ## **South America Cough Syrup Market Overview** As per MRFR analysis, the South America Cough Syrup Market Size was estimated at 507 (USD Million) in 2023.The South America Cough Syrup Market is expected to grow from 525(USD Million) in 2024 to 734 (USD Million) by 2035. The South America Cough Syrup Market CAGR (growth rate) is expected to be around 3.093% during the forecast period (2025 - 2035). ### **Key South America Cough Syrup Market Trends Highlighted** Numerous factors are driving notable changes in the South American cough syrup market. The rising incidence of respiratory diseases throughout the region, which has been made worse by elements including urbanization and pollution in large cities, is one of the main reasons propelling the market. The demand for cough syrups is impacted by governments' emphasis on public health measures to address respiratory infections. Additionally, as middle-class consumers' disposable incomes improve, they are spending more on healthcare products, such as over-the-counter drugs, which is driving the industry. The increasing popularity of natural and herbal cough medicines presents opportunities for the South American cough syrup market. Demand for cough syrups created with natural components is rising as people grow more health-conscious. Local producers now have the chance to take advantage of this trend by expanding and innovating their product lines in an effort to gain market share from consumers looking for healthier options. Additionally, there is a noticeable trend toward buying cough syrups online, which improves customer accessibility and enables firms to expand their market share. In order to meet the special requirements of pediatric patients, South American corporations have recently concentrated on creating cough syrup formulas that are kid-friendly. This is in response to parents' growing awareness of the efficacy and safety of medications. All things considered, the South American cough syrup market is being shaped by a confluence of growing consumer tastes, government assistance, and increased health awareness, creating an intriguing environment for manufacturers, healthcare providers, and stakeholders. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South America Cough Syrup Market Drivers** ### **Increasing Respiratory Disorders** The rising incidence of respiratory disorders in South America significantly drives the South America [Cough Syrup Market](../../../reports/cough-syrup-market-8217). According to the Pan American Health Organization, respiratory infections are among the leading causes of morbidity and mortality in the region, with annual estimates of over 10 million cases of acute respiratory infections. The continuous increase in urbanization and pollution levels further exacerbates these health issues, leading to a greater demand for cough syrup products. As patients seek relief from coughs caused by conditions such as bronchitis and pneumonia, major pharmaceutical companies like Novartis and Merck have noted upticks in prescription cough syrup sales, thus influencing market growth. ### **Rising Awareness of Health and Wellness** In South America, increased health consciousness has led to greater consumption of over-the-counter medications, including cough syrups. The Brazilian government has launched several health campaigns emphasizing the importance of treating symptoms effectively, which has contributed to higher sales of cough syrups. Public health initiatives have shown that about 60% of the population in major cities are now more aware of the benefits of treating coughs promptly, as reported by local health authorities. This awareness drives the South America Cough Syrup Market, encouraging leading brands like GSK and Bayer to expand their product lines to cater to evolving consumer preferences. ### **Aging Population** The demographic shift towards an aging population in South America plays a crucial role in bolstering the South America Cough Syrup Market. According to the United Nations Economic Commission for Latin America and the Caribbean, the percentage of people aged 65 and over in South America is projected to increase from 9% in 2020 to nearly 15% by 2035. This segment is more susceptible to respiratory illnesses, which directly correlates with a higher demand for cough syrup products. As a result, pharmaceutical companies such as Sanofi have ramped up their production and distribution strategies to capture this growing market segment. ### **Herbal and Natural Remedies Popularity** The trend towards herbal and natural remedies is gaining traction in South America, which is driving innovation and expansion in the South America Cough Syrup Market. A study conducted by the Brazilian Institute of Geography and Statistics indicates that approximately 35% of adults prefer using herbal products over conventional medications for minor ailments, including cough and cold symptoms. This inclination has prompted manufacturers to invest in research for new formulations that blend traditional herbal ingredients with modern cough syrups. Companies like Herbalife and Herbal Medicine in Colombia are capitalizing on this trend by introducing all-natural cough syrups. ## **South America Cough Syrup Market Segment Insights** ### **Cough Syrup Market Product Insights** The South America Cough Syrup Market is segmented into various product types, each catering to specific needs and preferences of consumers across the region. Among these, expectorants play a pivotal role as they help clear mucus and phlegm from the respiratory tract, offering relief to individuals suffering from productive coughs. This segment is known for its popularity due to the increasing prevalence of respiratory infections in the region, prompting demand for effective treatment options. Cough suppressants, designed to reduce the urge to cough, hold significant appeal as they provide symptomatic relief, particularly during nighttime, enhancing sleep quality for many patients. Antihistamines, often utilized in combination with other formulations, address coughs associated with allergies, making them an essential segment in the market, especially with rising allergic reactions among the population. Combination medications that integrate multiple active ingredients have garnered interest as they provide comprehensive relief by tackling various cough symptoms simultaneously, thus catering to a diverse customer base and enhancing treatment outcomes. The increasing awareness of health and wellness, along with the rise in self-medication trends, further drives the product segmentation within the South America Cough Syrup Market as consumers seek tailored solutions to their health concerns. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Cough Syrup Market Distribution Channel Insights** The Distribution Channel for the South America Cough Syrup Market plays a critical role in delivering products to consumers efficiently, addressing their health needs across various platforms. Retail pharmacies hold a significant position as they provide easy access to cough syrups, benefiting from the high foot traffic of customers seeking over-the-counter medications. In contrast, hospital pharmacies are essential for addressing severe cases and ensuring that patients receive the right medications under medical supervision, thus contributing to quality healthcare delivery. Online pharmacies are gaining momentum as consumer preferences shift towards digital platforms, allowing for convenient ordering and home delivery, particularly in urban areas. The growth of e-commerce in South America, bolstered by increased internet penetration and changing consumer behaviors, accelerates the prominence of this channel. Importantly, factors such as regulatory frameworks, regional health policies, and consumer trust in pharmacy systems significantly influence market dynamics and distribution efficiency, shaping how cough syrup products reach end-users across the continent. Understanding these diverse channels is vital as they collectively contribute to the South America Cough Syrup Market segmentation and cater to the diverse needs of the population. ### **Cough Syrup Market Regional Insights** The South America Cough Syrup Market exhibits diverse dynamics across its regional segmentation, prominently featuring key players such as Brazil, Mexico, Argentina, and the Rest of South America. Brazil leads the market, fueled by a robust pharmaceutical infrastructure and increasing consumer health awareness, making it a significant contributor to the overall market performance. Mexico showcases a growing penetration of cough syrup products, driven by urbanization and rising self-medication trends. Argentina, with its unique regulatory landscape and health challenges, plays a crucial role in the cough syrup demand, emphasizing the need for tailored formulations. The Rest of South America, comprising various smaller markets, presents opportunities for growth driven by increasing healthcare access and consumer education. Overall, the evolution in consumer preferences and advancements in distribution channels are shaping the competitive landscape, highlighting the region's potential in the South America Cough Syrup Market. Effective marketing strategies and innovation in product offerings are essential for capturing the growing market presence, indicating a bright future for the industry in South America. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South America Cough Syrup Market Key Players and Competitive Insights** The South America Cough Syrup Market is characterized by intense competition among several pharmaceutical companies that are trying to capture a larger share of this growing industry. As respiratory infections remain prevalent and seasonal variations influence demand, companies are focusing on innovative product formulations and strategic marketing approaches. The rise in disposable income and an increased emphasis on health among consumers are propelling market growth, driving firms to enhance their research and development efforts. Due to the diverse healthcare requirements across the region, competitive strategies often adapt to local preferences and regulatory landscapes, causing companies to differentiate their products through unique attributes, such as natural ingredients or targeted relief formulas. ### **Bristol-Myers Squibb** Bristol-Myers Squibb has established a significant presence in the South America Cough Syrup Market through its effective management of key brands and innovative product offerings. The company is recognized for its commitment to quality and patient-centric approaches, catering to the diverse health concerns of consumers in the region. With a strong distribution network and well-structured marketing strategies, Bristol-Myers Squibb successfully highlights its strengths, such as robust research capabilities and a reputation for delivering reliable healthcare solutions. Their focus on efficacy and safety further boosts consumer trust and preference, enabling the company to maintain solid sales performance amidst competitive pressures. ### **Novartis** Novartis plays a critical role in the South America Cough Syrup Market by offering a range of products aimed at alleviating respiratory conditions. The company benefits from its strong market presence and extensive expertise in pharmaceuticals, which allows it to introduce advanced formulations tailored to local needs. Key products within their portfolio address various types of cough, ensuring comprehensive care. Novartis’s strengths lie in its commitment to ongoing innovation and robust research initiatives, which have led to the development of effective over-the-counter and prescription cough medications. Additionally, strategic collaborations and mergers have strengthened Novartis’s foothold in the region, enabling them to adapt swiftly to changing market dynamics and consumer preferences. Their brand reputation, combined with an effective distribution strategy, positions Novartis as a formidable competitor in the South America Cough Syrup Market. ### **Key Companies in the South America Cough Syrup Market Include** ## **South America Cough Syrup Market Developments** The South America Cough Syrup Market has seen various developments recently, particularly involving major companies like Bristol-Myers Squibb, Novartis, and Merck and Co. In October 2023, Pfizer announced enhancements to its cough syrup product line in Brazil, responding to increased demand during the cold season. Additionally, Abbott Laboratories is collaborating with local pharmacies to expand the accessibility of its cough syrup products across Argentina. The market has reportedly experienced significant growth, estimated at over 6% annually, fueled by rising respiratory illnesses and an increased consumer focus on health, especially following the COVID-19 pandemic. In terms of mergers and acquisitions, Merck and Co. acquired a small local manufacturer in Brazil for revised formulations of cough syrups in September 2023, which is expected to boost their market share. Moreover, Reckitt Benckiser has invested substantially in Brazil to strengthen its production and distribution channels. Between 2021 and 2022, GlaxoSmithKline reported an uptick in its sales from cough syrup products driven by new marketing strategies across the continent. The increasing competition and market expansion initiatives by these companies mark a pivotal phase in the South America Cough Syrup Market. ## **South America Cough Syrup Market Segmentation Insights** ### **Cough Syrup Market Product Outlook** ### **Cough Syrup Market Distribution Channel Outlook** ### **Cough Syrup Market Regional Outlook** ## Market Drivers ### Rising Health Awareness There is a notable increase in health awareness among consumers in South America, which may positively influence the cough syrup market. As individuals become more informed about health issues, they are likely to seek effective remedies for common ailments, including coughs. This trend is reflected in the growing interest in self-medication and the preference for over-the-counter products. Market data suggests that the self-medication segment is expanding, with an estimated growth rate of 7% in the region. This shift towards proactive health management could lead to a higher consumption of cough syrups, as consumers prioritize quick and effective solutions for their health needs. ### Expansion of Retail Channels The expansion of retail channels in South America is poised to drive growth in the cough syrup market. Traditional pharmacies are increasingly complemented by supermarkets, convenience stores, and online platforms, enhancing accessibility for consumers. This diversification of retail options allows for greater visibility of cough syrup products, potentially increasing sales. Recent data indicates that the retail sector in South America has seen a growth rate of approximately 5% annually, which may correlate with increased availability of cough syrups. As consumers become more accustomed to purchasing health products from various outlets, the cough syrup market could experience a surge in demand, particularly for brands that effectively leverage these retail opportunities. ### Increasing Respiratory Disorders The prevalence of respiratory disorders in South America appears to be on the rise, which could significantly impact the cough syrup market. Factors such as urban pollution, seasonal allergies, and viral infections contribute to this trend. According to health statistics, respiratory diseases account for a substantial portion of healthcare burdens in the region. This increase in respiratory issues may lead to a higher demand for cough syrups, as consumers seek effective relief options. The cough syrup market is likely to benefit from this growing health concern, as more individuals turn to over-the-counter solutions for symptomatic relief. Furthermore, the rising awareness of respiratory health may encourage consumers to invest in preventive measures, thereby expanding the market for cough syrups. ### Government Regulations and Support Government regulations and support play a crucial role in shaping the cough syrup market in South America. Regulatory bodies are increasingly focusing on ensuring the safety and efficacy of over-the-counter medications, including cough syrups. This regulatory environment may lead to enhanced consumer trust in cough syrup products, potentially boosting sales. Additionally, government initiatives aimed at promoting public health could encourage the use of cough syrups as part of broader health campaigns. Recent policies have emphasized the importance of accessible healthcare solutions, which may further stimulate demand for cough syrups. As regulations evolve, the cough syrup market is likely to adapt, ensuring compliance while meeting consumer needs. ### Innovations in Product Formulations Innovations in product formulations are emerging as a key driver in the cough syrup market. Manufacturers are increasingly focusing on developing new formulations that cater to diverse consumer preferences, including sugar-free, alcohol-free, and herbal options. This trend aligns with the growing demand for products that are perceived as healthier and more natural. In South America, the market for herbal cough syrups has been gaining traction, with a reported increase in sales of approximately 10% over the past year. Such innovations not only attract health-conscious consumers but also enhance brand loyalty, as customers are more likely to choose products that align with their values and preferences. ## Future Outlook The [Cough Syrup Market](https://www.marketresearchfuture.com/reports/cough-syrup-market-8217) is projected to grow at 3.08% CAGR from 2025 to 2035, driven by increasing health awareness and demand for over-the-counter medications. **New opportunities:** - Development of herbal and natural cough syrup lines - Expansion into e-commerce platforms for direct sales - Partnerships with pharmacies for exclusive product offerings By 2035, the market is expected to achieve robust growth and increased consumer engagement. ## Segment Insights ### By Type: Expectorants (Largest) vs. Cough Suppressants (Fastest-Growing) In the South America cough syrup market, expectorants hold the largest market share, benefiting from their effectiveness in relieving productive coughs. Following closely, cough suppressants are gaining traction, particularly in urban areas where lifestyle-related coughs are prevalent. Antihistamines and combination medications play a supportive role, but their shares are comparatively smaller in this segment. The growth trends in this segment are driven by increasing awareness of respiratory health and the rising incidence of seasonal allergies. Cough suppressants are emerging as the fastest-growing category, fueled by consumers seeking immediate relief. Additionally, the shift towards over-the-counter medication encourages self-medication, further driving the demand for these products. Expectorants: Dominant vs. Combination Medications: Emerging Expectorants are the dominant segment in the type classification, known for their ability to loosen mucus and relieve coughs effectively. They are preferred by consumers for treating chronic respiratory conditions, ensuring their strong market presence. On the other hand, combination medications are emerging, blending the benefits of various active ingredients to address multiple symptoms simultaneously. This approach appeals to consumers looking for comprehensive relief from coughing, congestion, and allergy symptoms. With an increasing number of combination products being introduced, their market share is expected to grow as they meet the evolving needs of consumers. ### By Distribution Channel: Retail Pharmacy (Largest) vs. Online Pharmacy (Fastest-Growing) In the distribution channel segment, Retail Pharmacy holds the largest market share, characterized by its extensive network and established customer loyalty. This channel benefits from in-person consultations and immediate availability, which enhances customer trust and satisfaction. Meanwhile, Hospital Pharmacy also plays a significant role, offering specialized services that cater to patients requiring prescriptions from healthcare providers. The Online Pharmacy segment has emerged as the fastest-growing distribution channel, driven by the increasing adoption of e-commerce and changes in consumer behavior, particularly after the pandemic. Convenience, accessibility, and competitive pricing contribute to the growth of online sales, as more consumers turn to online platforms for purchasing cough syrups. The rapid expansion of delivery services and telemedicine further enhances the appeal of online pharmacies. Retail Pharmacy (Dominant) vs. Online Pharmacy (Emerging) Retail Pharmacy remains the dominant force in the distribution channel segment, delivering consistent sales through physical stores and personal interactions. Customers favor the immediacy of obtaining cough syrups along with the opportunity to seek professional advice from pharmacists. In contrast, Online Pharmacy is an emerging player that has seen a significant uptick due to the growing trend of digital purchasing. This channel appeals to tech-savvy consumers looking for 24/7 access to medications at competitive prices, often with home delivery options. The shift toward online shopping for health-related products is facilitated by improved logistics, greater awareness of e-pharmacies, and changing consumer preferences towards convenience and fast access. ## Regional Market Share Analysis ### Brazil : Robust Growth and Demand Trends Brazil holds a commanding market share of 50% in the South American cough syrup market, valued at $250.0 million. Key growth drivers include a rising prevalence of respiratory diseases and increased consumer awareness regarding health. Demand trends indicate a shift towards over-the-counter (OTC) products, supported by government initiatives promoting self-medication. Regulatory policies are becoming more favorable, enhancing the market's infrastructure and distribution channels, particularly in urban areas. ### Mexico : Increasing Health Awareness Drives Demand Mexico's cough syrup market is valued at $75.0 million, representing a growing segment in South America. The market is driven by increasing health awareness and a rise in respiratory ailments, particularly in urban centers like Mexico City and Guadalajara. Regulatory frameworks are evolving, with the government focusing on improving healthcare access. The demand for natural and herbal cough syrups is also on the rise, reflecting changing consumer preferences. ### Argentina : Resilient Market with Unique Dynamics Argentina's cough syrup market is valued at $150.0 million, accounting for 30% of the South American market. Key growth drivers include a high incidence of seasonal allergies and respiratory infections. The government has implemented policies to regulate pharmaceutical pricing, impacting market dynamics. Consumption patterns show a preference for branded products, with a notable demand for pediatric formulations, particularly in Buenos Aires and Córdoba. ### Rest of South America : Varied Demand Across Regions The Rest of South America holds a market value of $50.0 million, characterized by diverse consumer needs and preferences. Key growth drivers include increasing urbanization and healthcare access in countries like Chile and Peru. Regulatory policies vary significantly, affecting market entry for international players. Local demand is often influenced by cultural preferences for traditional remedies, creating a unique competitive landscape. ## Competitive Benchmarking The cough syrup market in South America is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an increasing prevalence of respiratory ailments, heightened consumer awareness regarding health and wellness, and a growing inclination towards over-the-counter (OTC) medications. Major players such as Johnson & Johnson (US), Pfizer Inc (US), and GlaxoSmithKline (GB) are strategically positioned to leverage these trends. Johnson & Johnson (US) focuses on innovation in product formulations, while Pfizer Inc (US) emphasizes regional expansion through strategic partnerships. GlaxoSmithKline (GB) appears to be concentrating on digital transformation initiatives to enhance customer engagement, collectively shaping a competitive environment that is increasingly reliant on innovation and consumer-centric strategies.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in a region where logistics can be challenging. The market structure is moderately fragmented, with several key players exerting influence over their respective segments. This fragmentation allows for niche players to thrive, yet the collective influence of major companies ensures that competition remains robust and dynamic. In October Johnson & Johnson (US) announced a new partnership with a local pharmaceutical company to enhance distribution channels across Brazil. This strategic move is likely to bolster their market presence and improve accessibility to their products, thereby increasing their competitive edge in a rapidly evolving market. The partnership underscores the importance of local knowledge and infrastructure in navigating the complexities of the South American market. In September Pfizer Inc (US) launched a new line of cough syrups specifically formulated for children, targeting a demographic that has shown increasing demand for pediatric health solutions. This initiative not only diversifies their product portfolio but also positions Pfizer as a leader in addressing the unique needs of younger patients, potentially capturing a significant market share in this segment. In August GlaxoSmithKline (GB) unveiled a digital health platform aimed at educating consumers about respiratory health and the appropriate use of cough syrups. This initiative reflects a broader trend towards digitalization in healthcare, suggesting that GSK is keen on enhancing consumer engagement and fostering brand loyalty through educational resources. Such strategies may prove essential in differentiating their offerings in a crowded marketplace. As of November current competitive trends indicate a strong shift towards digitalization, sustainability, and the integration of artificial intelligence in product development and marketing strategies. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability, as companies seek to meet the growing expectations of health-conscious consumers. ## Recent News & Developments The South America Cough Syrup Market has seen various developments recently, particularly involving major companies like Bristol-Myers Squibb, Novartis, and Merck and Co. In October 2023, Pfizer announced enhancements to its cough syrup product line in Brazil, responding to increased demand during the cold season. Additionally, Abbott Laboratories is collaborating with local pharmacies to expand the accessibility of its cough syrup products across Argentina. The market has reportedly experienced significant growth, estimated at over 6% annually, fueled by rising respiratory illnesses and an increased consumer focus on health, especially following the COVID-19 pandemic. In terms of mergers and acquisitions, Merck and Co. acquired a small local manufacturer in Brazil for revised formulations of cough syrups in September 2023, which is expected to boost their market share. Moreover, Reckitt Benckiser has invested substantially in Brazil to strengthen its production and distribution channels. Between 2021 and 2022, GlaxoSmithKline reported an uptick in its sales from cough syrup products driven by new marketing strategies across the continent. The increasing competition and market expansion initiatives by these companies mark a pivotal phase in the South America Cough Syrup Market. ## Report Scope | MARKET SIZE 2024 | 525.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 541.17(USD Million) | | MARKET SIZE 2035 | 733.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.08% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Johnson & Johnson (US), Pfizer Inc (US), GlaxoSmithKline (GB), Boehringer Ingelheim (DE), Sanofi (FR), Novartis (CH), Reckitt Benckiser Group (GB), AbbVie Inc (US), Mylan N.V. (US) | | Segments Covered | Type, Distribution Channel | | Key Market Opportunities | Growing demand for natural ingredients in cough syrup formulations presents a unique market opportunity. | | Key Market Dynamics | Rising consumer preference for natural ingredients drives innovation in cough syrup formulations across South America. | | Countries Covered | Brazil, Mexico, Argentina, Rest of South America | ## Frequently Asked Questions **Q: What was the overall market valuation of the cough syrup market in 2024?** A: The overall market valuation was $525.0 Million in 2024. **Q: What is the projected market valuation for the cough syrup market by 2035?** A: The projected market valuation for 2035 is $733.0 Million. **Q: What is the expected CAGR for the cough syrup market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 3.08%. **Q: Which distribution channel had the highest valuation in 2024?** A: In 2024, the Retail Pharmacy channel had the highest valuation at $300.0 Million. **Q: What are the projected valuations for cough suppressants from 2024 to 2035?** A: Cough suppressants are projected to grow from $210.0 Million in 2024 to a higher valuation by 2035. **Q: Who are the key players in the cough syrup market?** A: Key players include Johnson & Johnson, Pfizer Inc, GlaxoSmithKline, and others. **Q: What was the valuation of combination medications in 2024?** A: The valuation of combination medications in 2024 was $208.0 Million. **Q: How does the valuation of online pharmacies compare to hospital pharmacies in 2024?** A: In 2024, online pharmacies were valued at $233.0 Million, surpassing hospital pharmacies at $200.0 Million. **Q: What is the expected growth trend for antihistamines in the cough syrup market?** A: Antihistamines are expected to grow from $175.0 Million in 2024, indicating a positive trend. **Q: What segment is projected to have the highest growth in the cough syrup market by 2035?** A: Cough suppressants are likely to have the highest growth, given their strong valuation in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-cough-syrup-market-49730*